Covered recipient · General Payments record
ARIANA GONZALEZ-MELENDEZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2024
$6,297.16
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,412.50 | 2 |
| Food and Beverage | $762.21 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $3,898.77 | 15 |
| Acerta Pharma LLC | $116.87 | 2 |
| GlaxoSmithKline, LLC. | $59.97 | 3 |
| Amgen Inc. | $58.44 | 3 |
| E.R. Squibb & Sons, L.L.C. | $21.40 | 1 |
| Organon LLC | $19.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $91.02 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818550 | CMS |
| ABBVIE INC. | $124.99 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818552 | CMS |
| ABBVIE INC. | $8.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818554 | CMS |
| ABBVIE INC. | $25.89 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818556 | CMS |
| ABBVIE INC. | $8.46 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818558 | CMS |
| ABBVIE INC. | $26.06 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818560 | CMS |
| ABBVIE INC. | $8.68 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818562 | CMS |
| ABBVIE INC. | $30.00 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818564 | CMS |
| ABBVIE INC. | $8.69 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818566 | CMS |
| ABBVIE INC. | $25.00 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818568 | CMS |
| ABBVIE INC. | $36.48 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818570 | CMS |
| ABBVIE INC. | $8.49 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818572 | CMS |
| ABBVIE INC. | $84.05 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103818574 | CMS |
| ABBVIE INC. | $1,837.50 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134845 | CMS |
| ABBVIE INC. | $1,575.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134847 | CMS |
| Amgen Inc. | $13.37 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586834 | CMS |
| Amgen Inc. | $31.87 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586838 | CMS |
| Amgen Inc. | $13.20 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586836 | CMS |
| AstraZeneca Pharmaceuticals LP | $94.16 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104310144 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.71 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104336128 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.40 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101406929 | CMS |
| GlaxoSmithKline, LLC. | $17.66 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116565028 | CMS |
| GlaxoSmithKline, LLC. | $19.21 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115951102 | CMS |
| GlaxoSmithKline, LLC. | $23.10 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116450309 | CMS |
| Organon Llc | $19.26 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136290754 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.